|
|
|
Volumn 7 Suppl 1, Issue , 2001, Pages
|
|
Novel biologically based therapies for myeloma.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
CELL NUCLEUS ANTIGEN;
DNA BINDING PROTEIN;
ENDOTHELIAL CELL GROWTH FACTOR;
HELICASE;
INTERLEUKIN 6;
KU ANTIGEN;
LYMPHOKINE;
NUCLEAR PROTEIN;
THALIDOMIDE;
VASCULOTROPIN;
VASCULOTROPIN A;
XRCC5 PROTEIN, HUMAN;
ALLOTRANSPLANTATION;
AUTOTRANSPLANTATION;
GENETICS;
HUMAN;
IMMUNOLOGY;
METABOLISM;
MULTIPLE MYELOMA;
NEOVASCULARIZATION (PATHOLOGY);
REVIEW;
ANGIOGENESIS INHIBITORS;
ANTIGENS, NUCLEAR;
DNA HELICASES;
DNA-BINDING PROTEINS;
ENDOTHELIAL GROWTH FACTORS;
HUMANS;
INTERLEUKIN-6;
LYMPHOKINES;
MULTIPLE MYELOMA;
NEOVASCULARIZATION, PATHOLOGIC;
NUCLEAR PROTEINS;
THALIDOMIDE;
TRANSPLANTATION, AUTOLOGOUS;
TRANSPLANTATION, HOMOLOGOUS;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
|
EID: 0002983103
PISSN: 15289117
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (24)
|
|
References (31)
|
